PDF(Sci-hub)
Abstract：
OBJECTIVE: Medical compression therapy is used for non-invasive treatment of venous and lymphatic diseases. Medical compression therapy-associated adverse events and contraindications have been reported, although some contraindications are theoretically based. This consensus statement provides recommendations on medical compression therapy risks and contraindications.
METHODS: A systematic literature search of medical compression therapy publications reporting adverse events up until November 2017 was performed. A consensus panel comprising 15 international experts critically reviewed the publications and formulated the recommendations.
RESULTS: Sixty-two publications reporting medical compression therapy adverse events were identified. The consensus panel issued 21 recommendations on medical compression therapy contraindications and adverse event risk mitigation, in addition to reviewing medical compression therapy use in borderline indications. The most frequently reported non-severe medical compression therapy-associated adverse events included skin irritation, discomfort and pain. Very rare but severe adverse events, including soft tissue and nerve injury, were also identified.
CONCLUSIONS: This consensus statement summarises published medical compression therapy-associated adverse events and contraindications, and provides guidance on medical compression therapy. Severe medical compression therapy-associated adverse events are very rarely encountered if compression is used correctly and contraindications are considered.
METHODS: A systematic literature search of medical compression therapy publications reporting adverse events up until November 2017 was performed. A consensus panel comprising 15 international experts critically reviewed the publications and formulated the recommendations.
RESULTS: Sixty-two publications reporting medical compression therapy adverse events were identified. The consensus panel issued 21 recommendations on medical compression therapy contraindications and adverse event risk mitigation, in addition to reviewing medical compression therapy use in borderline indications. The most frequently reported non-severe medical compression therapy-associated adverse events included skin irritation, discomfort and pain. Very rare but severe adverse events, including soft tissue and nerve injury, were also identified.
CONCLUSIONS: This consensus statement summarises published medical compression therapy-associated adverse events and contraindications, and provides guidance on medical compression therapy. Severe medical compression therapy-associated adverse events are very rarely encountered if compression is used correctly and contraindications are considered.
摘要：
目的：医学压迫疗法用于静脉和淋巴疾病的非侵入性治疗。据报道，医学加压治疗相关的不良事件和禁忌症。尽管一些禁忌症是基于理论的。该共识声明提供了有关医疗加压治疗风险和禁忌症的建议。
方法：对截至2017年11月报告不良事件的医学加压治疗出版物进行了系统的文献检索。由15名国际专家组成的共识小组对出版物进行了严格审查，并提出了建议。
结果：确认了62篇报告药物压迫治疗不良事件的出版物。共识小组就医疗加压治疗禁忌症及不良事件风险缓解提出21项建议,除了回顾医学加压疗法在临界适应症中的使用。最常报告的非严重药物压迫治疗相关不良事件包括皮肤刺激，不适和疼痛。非常罕见但严重的不良事件，包括软组织和神经损伤，也被确认了。
结论：本共识声明总结了已发表的药物加压治疗相关不良事件和禁忌症，并提供医疗加压治疗的指导。如果正确使用压迫并考虑禁忌症，则很少遇到严重的药物压迫治疗相关不良事件。
方法：对截至2017年11月报告不良事件的医学加压治疗出版物进行了系统的文献检索。由15名国际专家组成的共识小组对出版物进行了严格审查，并提出了建议。
结果：确认了62篇报告药物压迫治疗不良事件的出版物。共识小组就医疗加压治疗禁忌症及不良事件风险缓解提出21项建议,除了回顾医学加压疗法在临界适应症中的使用。最常报告的非严重药物压迫治疗相关不良事件包括皮肤刺激，不适和疼痛。非常罕见但严重的不良事件，包括软组织和神经损伤，也被确认了。
结论：本共识声明总结了已发表的药物加压治疗相关不良事件和禁忌症，并提供医疗加压治疗的指导。如果正确使用压迫并考虑禁忌症，则很少遇到严重的药物压迫治疗相关不良事件。
